TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 120 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2020. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $29,632,000 | -45.8% | 393,782 | -80.6% | 0.01% | -33.3% |
Q1 2022 | $54,641,000 | -43.0% | 2,035,049 | +1.3% | 0.02% | -38.2% |
Q4 2021 | $95,838,000 | +15.2% | 2,009,191 | +60.4% | 0.03% | +3.0% |
Q3 2021 | $83,222,000 | -25.8% | 1,252,773 | -12.9% | 0.03% | -26.7% |
Q2 2021 | $112,224,000 | +12.4% | 1,438,406 | +36.2% | 0.04% | +2.3% |
Q1 2021 | $99,876,000 | -13.3% | 1,055,886 | +11.7% | 0.04% | -18.5% |
Q4 2020 | $115,198,000 | +22.2% | 945,411 | -12.4% | 0.05% | +5.9% |
Q3 2020 | $94,270,000 | +27.7% | 1,079,096 | -5.6% | 0.05% | +18.6% |
Q2 2020 | $73,805,000 | +172.9% | 1,142,671 | +88.7% | 0.04% | +126.3% |
Q1 2020 | $27,044,000 | -21.0% | 605,558 | +10.2% | 0.02% | 0.0% |
Q4 2019 | $34,238,000 | +103.0% | 549,657 | +22.5% | 0.02% | +72.7% |
Q3 2019 | $16,868,000 | +3.8% | 448,628 | +12.3% | 0.01% | +10.0% |
Q2 2019 | $16,257,000 | – | 399,436 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |